The immunohistochemical profile of mucinous carcinoma typically shows positive hormonal receptor status, with estrogen receptor (ER) positivity at 94% and progesterone receptor (PR) positivity at 80%, while being HER2-negative [7,8,9]. This evidence concerns the gene NR4A1 and mucinous adenocarcinoma.